Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: Effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats

Pharmacology and Toxicology

Volumn 86, Issue 5, 2000, Pages 197-202

  Harro, Jaanus ^a,b   Meriküla, Alar ^a   Lepiku, Martin ^a   Modiri, Ali Reza ^b,c   Rinken, Ago ^a   Oreland, Lars ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UPPSALA UNIVERSITY   (Sweden)

^c Pharmacia & Upjohn AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; AMPHETAMINE; DOPAMINE 2 RECEPTOR; NEUROTOXIN; NORADRENALIN; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DRUG RECEPTOR BINDING; HABITUATION; LOCOMOTION; LOCUS CERULEUS; MALE; NEOPHOBIA; NERVE ENDING; NERVE PROJECTION; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC NERVE; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; SUPERSENSITIVITY;

ANIMALIA;

EID: 0034039695     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.pto860501.x     Document Type: Article

References (40)

1. Al-Zahrani, S. S. A., A. S. A. Al-Ruwaitea, M.-Y. Ho, C. M. Bradshaw & E. Szabadi: Effect of destruction of noradrenergic neurones with DSP4 on performance on a free-operant timing schedule. Psychopharmacology 1998, 136, 235-242.
2. Archer, T.: Signalled and unsignalled avoidance impairments following noradrenaline depletion with DSP4: an hypothesis incorporating an associative and a non-associative factor. Scand. J. Psychol. 1983, 24, 75-87.
3. Archer, T., G. Jonsson & S. B. Ross: A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurones in the CNS of the rat. Brit. J. Pharmacol. 1984, 82, 249-257.
4. Aston-Jones, G., C. Chiang & T. Alexinsky: Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys sugests a role in vigilance. Prog. Brain Res. 1991, 88, 501-520.
5. Bruto, V., C. Beauchamp, R. M. Zacharko & H. Anisman: Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment. Psychopharmacology 1984, 83, 62-69.
6. Chrobak, J. J., D. L. DeHaven & T. J. Walsh: Depletion of brain norepinephrine with DSP-4 does not alter acquisition of performance of a radial-arm maze task. Behav. Neural Biol. 1985, 44, 144-150.
7. Cornwall-Jones, C. A., M. W. Decker, T. Gianulli, E.L. Wright & J.L. McGaugh: Norepinephrine depletion reduces the effects of social and olfactory experience. Brain Res. Bull. 1990, 25, 643-649.
8. Delini-Stula, A., E. Mogilnicka, E. Hunn & D. J. Dooley: Novelty-oriented behavior in the rat after selective damage of locus coeruleus projections by DSP-4, a new noradrenergic neurotoxin. Pharmacol. Biochem. Behav. 1984, 20, 613-618.
9. Di Lullo, S. L. & M.T. Martin-Iverson: Presynaptic dopaminergic neurotransmission mediates amphetamine-induced unconditioned but not amphetamine-conditioned locomotion and defecation in the rat. Brain Res. 1991, 568, 45-54.
10. Felice, L. J., J. D. Felice & P. T. Kissinger: Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem. 1978, 31, 1461-1465.
11. Foote, S. L., F. E. Bloom & G. Aston-Jones: Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiol. Rev. 1983, 63, 844-914.
12. Fornai, F., M. G. Alessandri, M. T. Torracca, L. Bassi, V. Scalori & G. U. Corsini: Noradrenergic modulation of metamphetamine-induced striatal dopamine depletion. Ann. N. Y. Acad. Sci. 1998, 844, 166-177.
13. Fornai, F., F. S. Giorgi, M. G. Alessandri, M. Giusiani & G. U. Corsini: Effects of pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on metamphetamine pharmacokinetics and striatal dopamine losses. J. Neurochem. 1999, 72, 777-784.
14. Fornai, F., M. T. Torracca, L. Bassi, D. A. D'Errigo, V. Scalori & G. U. Corsini: Norepinephrine loss selectively enhances nigrostriatal dopamine depletion in mice and rats. Brain Res. 1996, 735, 349-353.
15. Fritschy, J.-M. & R. Grzanna: Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 1989, 30, 181-197.
16. Guan, X., J. L. Blank & D. E. Dluzen: Role of olfactory bulb norepinephrine in the identification and recognition of chemical clues. Physiol. Behav. 1993, 53, 437-441.
17. Hallman, H. & G. Jonsson: Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons. Eur. J. Pharmacol. 1984, 103, 269-278.
18. Hallman, H., E. Sundström & G. Jonsson: Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNS. J. Neural Transm. 1984, 60, 89-102.
19. Harro, J., S. S. Jossan & L. Oreland: Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992, 346, 425-431.
20. Harro, J., L. Oreland, E. Vasar & J. Bradwejn: Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol. 1995, 5, 272-280.
21. Harro, J., R. Pähkla, A.-R. Modiri, M. Harro, A. Kask & L. Oreland: Dose-dependent effects of noradrenergic denervation by DSP-4 treatment on forced swimming and ß-adrenoceptor binding in the rat. J. Neural Transm. 1999, 106, 619-629.
22. Hollister, A. S., G. R. Breese & B. R. Cooper: Comparison of tyrosine hydroxylase and dopamine-ß-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced locomotor activity. Psychopharmacologia 1974, 36, 1-16.
23. Hughes, J. A. & S. C. Stanford. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a micro-dialysis study in vivo. Psychopharmacology 1998, 136, 299-303.
24. Jonsson, G., H. Hallman, F. Ponzio & S. Ross: DSP-4 [N(2-chloroethyl)-N-ethyl-2-bromobenzylamine]: a useful denervation tool for central and peripheral noradrenaline neurons. Eur. J. Pharmacol. 1981, 72, 173-188.
25. Jonsson, G., H. Hallman & E. Sundström: Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Neuroscience 1982, 7, 2895-2907.
26. Kask, A., J. Harro, P. Tuomainen, L. Rägo & P. T. Männistö: Overflow of noradrenaline and dopamine in frontal cortex after [N(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 355, 267-272.
27. Kuczenski, R. & D. S. Segal: Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 1997, 68, 2032-2037.
28. Lategan, A. J., M. R. Marien & F. C. Colpaert: Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci. 1992, 50, 995-999.
29. Mogilnicka, E., D. J. Dooley, C. G. Boissard & A. Delini-Stula: Facilitation of shock-induced fighting in the rat after DSP-4, a selective noradrenergic neurotoxin. Pharmacol. Biochem. Behav. 1983, 18, 625-628.
30. Mogilnicka, E., C. G. Boissard, C. Hunn & A. Delini-Stula: Suppressant effect of REM sleep deprivation on neophobia in normal rats and in rats with selective DSP-4 induced damage of locus coeruleus neurons. Pharmacol. Biochem. Behav. 1985, 23, 93-97.
31. Ohno, M., A. Yoshimatsu, M. Kobayashi & S. Watanabe: ß-Adrenergic dysfunction exacerbates impairment of working memory induced by hippocampal NMDA receptor blockade in rats. Eur. J. Pharmacol. 1996, 307, 21-26.
32. Olpe, H. R., J. Laszlo, D. J. Dooley, J. Heid & M. W. Steinmann: Decreased activity of locus coeruleus neurons in the rat after DSP-4 treatment. Neurosci. Lett. 1983, 40, 81-84.
33. Pucilowski, O., E. Trzaskowska, W. Kostowski & L. Valzelli: Norepinephrine-mediated suppression of apomorphine-induced aggression and locomotor activity in the rat amygdala. Pharmacol. Biochem. Behav. 1987, 26, 217-222.
34. Roberts, D. C. S., A. P. Zis & H. C. Fibiger: Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent noninvolvement of norepinephrine. Brain Res. 1975, 93, 441-454.
35. Ross, S. B.: Long-term effect of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Brit. J. Pharmacol. 1976, 58, 521-527.
36. Ruotsalainen, S., A. Haapalinna, P. J. Riekkinen & J. Sirviö: Dexmedetomidine reduces response tendency, but not accuracy of rats in attention and short-term memory tasks. Pharmacol. Biochem. Behav. 1997, 56, 31-40.
37. Sharp, T. & T. Zetterström: In vivo measurement of monoamine neurotransmitter release using brain microdialysis. In: Monitoring neuronal activity: a practical approach. Ed.: J.A. Stamford. Oxford University Press, Oxford, 1992, 147-177.
38. 1A receptor agonist, facilitates cortical acetyleholine release by a mechanism different from that of 8-OH-DPAT in awake rats. Neuropharmacology 1997, 36, 1733-1739.
39. Ögren, S. O., T. Archer & S. B. Ross: Evidence for a role of the locus coeruleus noradrenaline system in learning. Neurosci. Lett. 1980, 20, 351-356.
40. Ögren, S. O., T. Archer & C. Johansson: Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat. Neurosci. Lett. 1983, 43, 327-331.